Weitere Kapitel dieses Buchs durch Wischen aufrufen
The final section will discuss the issue of corporate social responsibility (CSR). CSR goes beyond the legal and regulatory requirements. However, the tobacco companies have used CSR to enhance their image within the market. It will be argued that the marketing of a lethal product cannot be reconciled with the concept of CSR. According to the WHO (World Health Organization Technical manual, 2010), tobacco companies have tried to prevent the implementation of health policies. WHO’s FCTC intends to protect the political decision-making process from vested interests. It is argued that as tobacco is one of the deadliest products, nicotine should come under a similar regulatory framework as other drugs.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Charney, J. I. (1983). Transnational corporations and developing public international law. Duke Law Journal, 327(4), 748–788. CrossRef
Drope, S., & Glantz, S. A. (2003). British Columbia capital regional district 100 % smoke free bylaw: A successful public health campaign despite industry opposition. Tobacco Control, 12, 264–269. CrossRef
Friedman, L. C. (2009). Tobacco industry use of corporate social responsibility tactics as a sword and a shield on second hand smoke issues. Journal of Law Medicine & Ethics, 37(4), 819–827. CrossRef
Gilpin, R. (2001). Global political economy: Understanding the international economic order. Princeton, NJ: Princeton University Press.
Ioannidis, J. P. A., Henriksen, L. et al. (2013). Endgame: Engaging the tobacco industry in its own elimination. European Journal of Clinical Investigation, 43(12), 1366–1370. CrossRef
Kelder, G., & Daynard, R. (1997). The role of litigation in the effective control of the sale and use of tobacco. Stanford Law and Policy Review, 8(1), 63, 71.
Keohane, R. O., & Nye, J. (1972). Transnational relations and world Politics. Cambridge, MA: Harvard University Press. CrossRef
Liberman, J. (2003). Where to for tobacco regulation: Time for new approaches? Drug and Alcohol Review, 22(4), 461–469. CrossRef
Malone, R. E., McDaniel, P. A. et al. (2014). Report commissioned by cancer research UK. London: Cancer Research UK.
Mamudu, H. M., Hammond, R. et al. (2008). Tobacco industry attempts to counter the World Bank report, curbing the epidemic and obstruct the WHO framework convention on tobacco control. Social Science & Medicine, 67, 1690–1699. CrossRef
McGarity, T. O., Kysar, D. A. et al. (2006). The truth about torts: Lawyers, guns, and money. July, 2006. CPR White Paper #603. Washington, DC: A Center for Progressive Reform Publication.
McWilliams, A., & Siegel, D. S. (2001). Corporate responsibility: A theory of the firm perspective. Academy of Management Review, 26(1), 117–127.
Proctor, R. N. (2001). Tobacco and the global lung cancer epidemic. Nature Reviews Cancer, 1, 82–86. CrossRef
Proctor, R. N. (2012). The history of the cigarette-lung cancer link: Evidentiary traditions, corporate denial, global toll. Tobacco Control, 21(2), 87–91. CrossRef
Proctor, R. N. (2013). Why ban the sale of cigarettes? The case for abolition. Tobacco Control, 22(Suppl. 1), i27–i30. CrossRef
Sklair, L. (2002). The transnational capitalist class and global politics: Deconstructing the corporate – state connection. International Political Science Review, 23(2), 59–174. CrossRef
White, J., & Bero, L. A. (2004). Public health under attack: The American Stop Smoking Intervention Study (ASSIST) and the Tobacco Industry. American Journal of Public Health, 94, 240–250. CrossRef
World Health Organization (WHO). (2000b). Advancing knowledge on regulating tobacco products. Monograph. Geneva: WHO.
Zeller, M. (2000). Exposure and harm reduction. Paper presented at the International Conference: Advancing Knowledge on Regulating Tobacco Products, Oslo, 9–11 February, 2000.
- Corporate Social Responsibility and Social Costs
Neuer Inhalt/© Stellmach, Neuer Inhalt/© Maturus, Pluta Logo/© Pluta